147 related articles for article (PubMed ID: 37949836)
1. Effective Inhibition of TDP-43 Aggregation by Native State Stabilization.
Yang L; Jasiqi Y; Zettor A; Vadas O; Chiaravalli J; Agou F; Lashuel HA
Angew Chem Int Ed Engl; 2024 Jan; 63(3):e202314587. PubMed ID: 37949836
[TBL] [Abstract][Full Text] [Related]
2. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage.
Kumar ST; Nazarov S; Porta S; Maharjan N; Cendrowska U; Kabani M; Finamore F; Xu Y; Lee VM; Lashuel HA
Nat Neurosci; 2023 Jun; 26(6):983-996. PubMed ID: 37248338
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice.
Medina DX; Orr ME; Oddo S
Neurobiol Aging; 2014 Jan; 35(1):79-87. PubMed ID: 23954172
[TBL] [Abstract][Full Text] [Related]
4. TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine approaches for patients with TDP-43 pathology.
Helmold BR; Pauss KE; Ozdinler PH
Drug Discov Today; 2023 Nov; 28(11):103769. PubMed ID: 37714405
[TBL] [Abstract][Full Text] [Related]
5. Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils.
Shimonaka S; Nonaka T; Suzuki G; Hisanaga S; Hasegawa M
J Biol Chem; 2016 Apr; 291(17):8896-907. PubMed ID: 26887947
[TBL] [Abstract][Full Text] [Related]
6. The Role of TDP-43 in Neurodegenerative Disease.
Liao YZ; Ma J; Dou JZ
Mol Neurobiol; 2022 Jul; 59(7):4223-4241. PubMed ID: 35499795
[TBL] [Abstract][Full Text] [Related]
7. Strategies in the design and development of (TAR) DNA-binding protein 43 (TDP-43) binding ligands.
Rao PPN; Shakeri A; Zhao Y; Calon F
Eur J Med Chem; 2021 Dec; 225():113753. PubMed ID: 34388383
[TBL] [Abstract][Full Text] [Related]
8. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy.
Chen HJ; Topp SD; Hui HS; Zacco E; Katarya M; McLoughlin C; King A; Smith BN; Troakes C; Pastore A; Shaw CE
Brain; 2019 Dec; 142(12):3753-3770. PubMed ID: 31605140
[TBL] [Abstract][Full Text] [Related]
9. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.
Cohen TJ; Lee VM; Trojanowski JQ
Trends Mol Med; 2011 Nov; 17(11):659-67. PubMed ID: 21783422
[TBL] [Abstract][Full Text] [Related]
10. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects.
Langellotti S; Romano V; Romano G; Klima R; Feiguin F; Cragnaz L; Romano M; Baralle FE
Dis Model Mech; 2016 Jun; 9(6):659-69. PubMed ID: 27101846
[TBL] [Abstract][Full Text] [Related]
11. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.
Mompeán M; Romano V; Pantoja-Uceda D; Stuani C; Baralle FE; Buratti E; Laurents DV
J Biol Chem; 2017 Jul; 292(28):11992-12006. PubMed ID: 28566288
[TBL] [Abstract][Full Text] [Related]
12. Cryo-EM observation of the amyloid key structure of polymorphic TDP-43 amyloid fibrils.
Sharma K; Stockert F; Shenoy J; Berbon M; Abdul-Shukkoor MB; Habenstein B; Loquet A; Schmidt M; Fändrich M
Nat Commun; 2024 Jan; 15(1):486. PubMed ID: 38212334
[TBL] [Abstract][Full Text] [Related]
13. Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration.
Gendron TF; Josephs KA; Petrucelli L
Neuropathol Appl Neurobiol; 2010 Apr; 36(2):97-112. PubMed ID: 20202122
[TBL] [Abstract][Full Text] [Related]
14. TDP-43 pathology: From noxious assembly to therapeutic removal.
Keating SS; San Gil R; Swanson MEV; Scotter EL; Walker AK
Prog Neurobiol; 2022 Apr; 211():102229. PubMed ID: 35101542
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic modulation of folding and aggregation energy landscape by DNA binding of functional domains of TDP-43.
Patni D; Jha SK
Biochim Biophys Acta Proteins Proteom; 2023 Jul; 1871(4):140916. PubMed ID: 37061152
[TBL] [Abstract][Full Text] [Related]
16. Molecular dissection of TDP-43 proteinopathies.
Hasegawa M; Nonaka T; Tsuji H; Tamaoka A; Yamashita M; Kametani F; Yoshida M; Arai T; Akiyama H
J Mol Neurosci; 2011 Nov; 45(3):480-5. PubMed ID: 21678031
[TBL] [Abstract][Full Text] [Related]
17. RNA-binding proteins with prion-like domains in health and disease.
Harrison AF; Shorter J
Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
[TBL] [Abstract][Full Text] [Related]
18. Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.
Guo L; Shorter J
Cold Spring Harb Perspect Med; 2017 Sep; 7(9):. PubMed ID: 27920024
[TBL] [Abstract][Full Text] [Related]
19. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
20. [TDP-43 proteinopathies, toward understanding of the molecular pathogenesis].
Hasegawa M; Nonaka T; Yamashita M; Kametani F; Arai T; Yoshida M; Hashizume Y; Tsuchiya K; Akiyama H
Rinsho Shinkeigaku; 2009 Nov; 49(11):783-5. PubMed ID: 20030209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
